Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/the-new-england-journal-of-medicine/risk-of-cardiovascular-disease-in-patients-with-nonalcoholic-fatty-HWQrjH1c6G
References (72)
-
S. Shoelson, Laura Herrero, A. Naaz (2007)
Obesity, inflammation, and insulin resistance.Gastroenterology, 132 6
-
Yu-Cheng Lin, H. Lo, Jong-Dar Chen (2005)
Sonographic fatty liver, overweight and ischemic heart disease.World journal of gastroenterology, 11 31
-
A. Sanyal, N. Chalasani, K. Kowdley, A. McCullough, A. Diehl, N. Bass, B. Neuschwander‐Tetri, J. Lavine, J. Tonascia, A. Unalp, M. Natta, J. Clark, E. Brunt, D. Kleiner, J. Hoofnagle, Patricia Robuck (2010)
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.The New England journal of medicine, 362 18
-
L. Adams, J. Lymp, J. Sauver, S. Sanderson, K. Lindor, A. Feldstein, P. Angulo (2005)
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.Gastroenterology, 129 1
-
S. Wannamethee, L. Lennon, A. Shaper (2008)
The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.Atherosclerosis, 201 1
-
H. Yki-Järvinen (2007)
ATVB In Focus Metabolic Syndrome and Atherosclerosis -
Douglas Lee, J. Evans, S. Robins, P. Wilson, Irene Albano, C. Fox, Thomas Wang, E. Benjamin, R. D'Agostino, R. Vasan (2007)
Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart StudyArteriosclerosis, Thrombosis, and Vascular Biology, 27
-
Nimantha Alwis, C. Day (2008)
Non-alcoholic fatty liver disease: the mist gradually clears.Journal of hepatology, 48 Suppl 1
-
R. Belfort, S. Harrison, K. Brown, Celia Darland, J. Finch, J. Hardies, B. Balas, A. Gastaldelli, F. Tio, Joseph Pulcini, R. Berria, Jennie Ma, S. Dwivedi, R. Havranek, C. Fincke, R. DeFronzo, G. Bannayan, S. Schenker, K. Cusi (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.The New England journal of medicine, 355 22
-
(2010)
For personal use only. No other uses without permission. Copyright © 2010 Massachusetts Medical Society -
S. Shoelson, Jongsoon Lee, A. Goldfine (2006)
Inflammation and insulin resistance.The Journal of clinical investigation, 116 7
-
A. Lincoff, K. Wolski, S. Nicholls, S. Nissen (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.JAMA, 298 10
-
F. Schaffner, H. Thaler (1986)
Nonalcoholic fatty liver disease.Progress in liver diseases, 8
-
M. Badman, J. Flier (2007)
The adipocyte as an active participant in energy balance and metabolism.Gastroenterology, 132 6
-
M. Talim (2007)
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic PatientsDiabetes Care, 30
-
M. Hamaguchi, T. Kojima, N. Takeda, C. Nagata, J. Takeda, H. Sarui, Y. Kawahito, Naohisa Yoshida, A. Suetsugu, Takahiro Kato, J. Okuda, K. Ida, T. Yoshikawa (2007)
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.World journal of gastroenterology, 13 10
-
N. Villanova, S. Moscatiello, S. Ramilli, E. Bugianesi, D. Magalotti, E. Vanni, M. Zoli, G. Marchesini (2005)
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseHepatology, 42
-
J. Petit, B. Guiu, B. Terriat, R. Loffroy, I. Robin, V. Petit, B. Bouillet, M. Brindisi, L. Duvillard, P. Hillon, J. Cercueil, B. Vergès (2009)
Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients.The Journal of clinical endocrinology and metabolism, 94 10
-
G. Targher, M. Chonchol, L. Miele, G. Zoppini, Isabella Pichiri, M. Muggeo (2009)
Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.Seminars in thrombosis and hemostasis, 35 3
-
S. Dam-Larsen, M. Franzmann, I. Andersen, P. Christoffersen, L. Jensen, T. Sørensen, U. Becker, F. Bendtsen (2004)
Long term prognosis of fatty liver: risk of chronic liver disease and deathGut, 53
-
H. Kim, D. Kim, K. Huh (2009)
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome.Atherosclerosis, 204 2
-
C. Ruhl, J. Everhart (2009)
Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.Gastroenterology, 136 2
-
R. Schindhelm, J. Dekker, G. Nijpels, L. Bouter, C. Stehouwer, R. Heine, M. Diamant (2007)
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.Atherosclerosis, 191 2
-
H. Vőlzke, D. Robinson, V. Kleine, R. Deutscher, W. Hoffmann, J. Ludemann, U. Schminke, C. Kessler, U. John (2005)
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.World journal of gastroenterology, 11 12
-
Á. Brea, D. Mosquera, E. Martín, A. Arizti, J. Cordero, E. Ros (2005)
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control StudyArteriosclerosis, Thrombosis, and Vascular Biology, 25
-
G. Cooke, S. Segal, A. Hill (2002)
Toll-like receptor 4 polymorphisms and atherogenesis.The New England journal of medicine, 347 24
-
K. Petersen, S. Dufour, D. Befroy, M. Lehrke, Rosa Hendler, G. Shulman (2005)
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.Diabetes, 54 3
-
A. Fraser, Ross Harris, N. Sattar, S. Ebrahim, G. Smith, D. Lawlor (2007)
Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women’s Heart and Health Study and Meta-AnalysisArteriosclerosis, Thrombosis, and Vascular Biology, 27
-
G. Perseghin, G. Lattuada, F. Cobelli, A. Esposito, E. Belloni, G. Ntali, F. Ragogna, T. Canu, P. Scifo, A. Maschio, L. Luzi (2007)
Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liverHepatology, 47
-
S. Thuy, R. Ladurner, V. Volynets, S. Wagner, S. Strahl, A. Königsrainer, K. Maier, S. Bischoff, I. Bergheim (2008)
Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.The Journal of nutrition, 138 8
-
J. Browning (2006)
Statins and hepatic steatosis: Perspectives from the Dallas Heart StudyHepatology, 44
-
R. Haring, H. Wallaschofski, M. Nauck, M. Dörr, S. Baumeister, H. Völzke (2009)
Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma‐glutamyl transpeptidase levelsHepatology, 50
-
S. Harrison, C. Day (2007)
Benefits of lifestyle modification in NAFLDGut, 56
-
M. Ekstedt, L. Franzén, U. Mathiesen, L. Thorelius, M. Holmqvist, G. Bodemar, S. Kechagias (2006)
Long‐term follow‐up of patients with NAFLD and elevated liver enzymesHepatology, 44
-
E. Ruttmann, L. Brant, H. Concin, G. Diem, K. Rapp, H. Ulmer (2005)
Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.Circulation, 112 14
-
G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Arcaro, C. Day (2007)
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C.Journal of hepatology, 46 6
-
N. Stefan, K. Kantartzis, H. Häring (2008)
Causes and metabolic consequences of Fatty liver.Endocrine reviews, 29 7
-
K. Petersen, S. Dufour, D. Savage, S. Bilz, Jerry Solomon, S. Yonemitsu, G. Cline, D. Befroy, L. Zemany, B. Kahn, X. Papademetris, D. Rothman, G. Shulman (2007)
Inaugural Article: The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndromeProceedings of the National Academy of Sciences of the United States of America
-
Anna Więckowska, B. Papouchado, Zhengzheng Li, R. Lopez, N. Zein, A. Feldstein (2008)
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic SteatohepatitisThe American Journal of Gastroenterology, 103
-
H. Tilg, A. Moschen (2008)
Insulin resistance, inflammation, and non-alcoholic fatty liver diseaseTrends in Endocrinology & Metabolism, 19
-
S. Sookoian, C. Pirola (2008)
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.Journal of hepatology, 49 4
-
S. Goland, S. Shimoni, T. Zornitzki, H. Knobler, Orly Azoulai, Gaby Lutaty, E. Melzer, A. Orr, A. Caspi, S. Malnick (2006)
Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging AssessmentJournal of Clinical Gastroenterology, 40
-
S. Mirbagheri, A. Rashidi, S. Abdi, D. Saedi, M. Abouzari (2007)
Liver: an alarm for the heart?Liver International, 27
-
M. Yoneda, H. Mawatari, K. Fujita, Hiroshi Iida, K. Yonemitsu, S. Kato, Hirokazu Takahashi, H. Kirikoshi, M. Inamori, Y. Nozaki, Y. Abe, K. Kubota, S. Saito, T. Iwasaki, Y. Terauchi, S. Togo, S. Maeyama, A. Nakajima (2007)
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASHJournal of Gastroenterology, 42
-
G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Zoppini, Isabella Pichiri, C. Sorgato, L. Zenari, E. Bonora (2010)
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.Journal of hepatology, 53 4
-
D. Lee, K. Silventoinen, G. Hu, D. Jacobs, P. Jousilahti, J. Sundvall, J. Tuomilehto (2006)
Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.European heart journal, 27 18
-
A. Fracanzani, L. Burdick, S. Raselli, P. Pedotti, L. Grigore, G. Santorelli, L. Valenti, A. Maraschi, A. Catapano, S. Fargion (2008)
Carotid artery intima-media thickness in nonalcoholic fatty liver disease.The American journal of medicine, 121 1
-
G. Musso, R. Gambino, F. Michieli, M. Cassader, M. Rizzetto, M. Durazzo, Emanuela Fagà, B. Silli, G. Pagano (2003)
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitisHepatology, 37
-
B. Cha, H. Kim (2003)
Metabolic Syndrome and Cardiovascular DiseaseKorean Circulation Journal, 33
-
Winston Dunn, R. Xu, D. Wingard, C. Rogers, P. Angulo, Z. Younossi, J. Schwimmer (2008)
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort StudyThe American Journal of Gastroenterology, 103
-
Ryan McKimmie, Kurt Daniel, J. Carr, D. Bowden, B. Freedman, T. Register, F. Hsu, Kurt Lohman, Richard Weinberg, L. Wagenknecht (2008)
Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart StudyThe American Journal of Gastroenterology, 103
-
G. Targher, L. Bertolini, Felice Poli, S. Rodella, Luca Scala, Roberto Tessari, L. Zenari, Giancarlo Falezza (2005)
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.Diabetes, 54 12
-
D. Groll, T. To, C. Bombardier, J. Wright (2005)
The development of a comorbidity index with physical function as the outcome.Journal of clinical epidemiology, 58 6
-
N. Matikainen, S. Mänttäri, J. Westerbacka, S. Vehkavaara, N. Lundbom, H. Yki-Järvinen, M. Taskinen (2007)
Postprandial lipemia associates with liver fat content.The Journal of clinical endocrinology and metabolism, 92 8
-
J. Schwimmer, Cynthia Behling, R. Newbury, R. Deutsch, C. Nievergelt, N. Schork, J. Lavine (2005)
Histopathology of pediatric nonalcoholic fatty liver diseaseHepatology, 42
-
G. Sabio, Madhumita Das, A. Mora, Zhiyou Zhang, J. Jun, H. Ko, T. Barrett, Jason Kim, R. Davis (2008)
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin ResistanceScience, 322
-
R. Lautamäki, R. Borra, R. Borra, P. Iozzo, M. Komu, T. Lehtimäki, M. Salmi, S. Jalkanen, K. Airaksinen, J. Knuuti, R. Parkkola, P. Nuutila (2006)
Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.American journal of physiology. Endocrinology and metabolism, 291 2
-
Nila Rafiq, Chunhong Bai, Yun Fang, Manirath Srishord, A. McCullough, T. Gramlich, Z. Younossi (2009)
Long-term follow-up of patients with nonalcoholic fatty liver.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 7 2
-
M. Bajaj, S. Suraamornkul, T. Pratipanawatr, L. Hardies, Wilailak Pratipanawatr, L. Glass, E. Cersosimo, Y. Miyazaki, R. DeFronzo (2003)
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.Diabetes, 52 6
-
C. Söderberg, P. Stål, J. Askling, H. Glaumann, G. Lindberg, J. Marmur, R. Hultcrantz (2010)
Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐upHepatology, 51
-
C. Matteoni, Z. Younossi, T. Gramlich, N. Boparai, Yao‐Chang Liu, A. McCullough (1999)
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.Gastroenterology, 116 6
-
G. Targher, L. Bertolini, S. Rodella, G. Lippi, M. Franchini, G. Zoppini, M. Muggeo, C. Day (2008)
NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in MenObesity, 16
-
G. Targher, F. Marra, G. Marchesini (2008)
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?Diabetologia, 51
-
W. Goessling, W. Goessling, J. Massaro, R. Vasan, R. Vasan, R. D'Agostino, R. Ellison, C. Fox, C. Fox (2008)
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.Gastroenterology, 135 6
-
G. Targher, L. Bertolini, R. Padovani, L. Zenari, G. Zoppini, G. Falezza (2004)
Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation.Diabetes care, 27 10
-
C. Day (2006)
From fat to inflammation.Gastroenterology, 130 1
-
G. Marchesini, S. Moscatiello, S. Domizio, G. Forlani (2008)
Obesity-associated liver disease.The Journal of clinical endocrinology and metabolism, 93 11 Suppl 1
-
D. Savage, K. Petersen, G. Shulman (2007)
Disordered lipid metabolism and the pathogenesis of insulin resistance.Physiological reviews, 87 2
-
K. Yun, Chan Shin, Y. Yoon, H. Park (2009)
Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.Atherosclerosis, 205 2
-
(2005)
Fatty liver as a determinant of atherosclerosis -
Steven Nissen, K. Wolski (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.The New England journal of medicine, 356 24
-
G. Porto, M. Sousa (2010)
World J Gastroenterol
- Publisher
- The New England Journal of Medicine
- Copyright
- Copyright © 2010 Massachusetts Medical Society. All rights reserved.
- ISSN
- 0028-4793
- eISSN
- 1533-4406
- DOI
- 10.1056/NEJMra0912063
- pmid
- 20879883
- Publisher site
- See Article on Publisher Site
Abstract
Growing evidence suggests that nonalcoholic fatty liver disease is associated with an increased risk of cardiovascular disease beyond that conferred by established risk factors.
Journal
The New England Journal of Medicine – The New England Journal of Medicine
Published: Sep 30, 2010